Singapore
Regulatory . Certification . Licensing . Assurance
Our Markets
Why Singapore
Singapore is a prime choice for pharmaceutical companies to register their products due to its strategic location and stable business environment, making it an attractive destination for pharmaceutical companies seeking to register and commercialize their products in the Asia-Pacific region. Singapore's stable political and economic environment, strong intellectual property protection and government incentives further enhance its appeal.
​
The Health Sciences Authority (HSA) upholds international standards of robust regulatory framework, ensuring swift and reliable product reviews with efficient approval processes. The HSA is committed to timely reviews of product registrations, enabling companies to bring their products to market more quickly compared to some other jurisdictions. The adherence to global standards facilitates a smoother registration process for pharmaceutical products that have already been approved by reputable regulatory authorities such as the U.S. Food and Drug Administration (FDA) or the European Medicines Agency (EMA).
Singapore is also known for its attractive tax system. The country has a low corporate tax rate, tax incentives for specific industries (including trading and logistics), and a network of Double Taxation Agreements (DTAs) with numerous countries. The Goods and Services Tax (GST) in Singapore is also relatively low. These factors make Singapore an appealing location for international trade and business operations.
